Investigations

Avandia, a Case of Deja Vu all over again

ByVera Sharav February 20, 2010March 22, 2018

Miscellaneous

Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition?
October 26, 2006November 21, 2014

Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition? Fri, 19 Aug 2005 Below, two companion pieces: An Op Ed in the Los Angeles Times, by Stuart Kirk, a professor of social welfare at UCLA, addresses psychiatry’s conundum: the…

Read More Are we all going mad, or are the experts crazy? / Are psychiatric drugs an assault on the human condition?
Miscellaneous

Jeffrey Drazen editor NEJM Turns Activist on Drug Trials
October 26, 2006November 21, 2014

Jeffrey Drazen editor NEJM Turns Activist on Drug Trials Thu, 26 May 2005 Journal editors, one by one are trying to retrieve the integrity of their publications, at last recognizing that the pharamaceutical industry is a corrupting factor in medical research and the information disseminated about medicine. Jeffrey Drazen who…

Read More Jeffrey Drazen editor NEJM Turns Activist on Drug Trials
AHRP Speaks Out | Board of Directors | Business of Medicine | Corporate-Corrupted Medicine | Corrupt Practices | Corrupt Public Health | Investigations | Lawsuits | Miscellaneous | Newsflash

The Stench of Politics is Endangering Lives by Corroding the Practice of Medicine
October 14, 2022October 24, 2022

Political Influence is Corroding the Practice of Medicine – Thereby Endangering Lives On October 11th, the public had an opportunity to bear witness to a hearing at which Dr. Meryl Nass had the opportunity to confront the medical collaborators who participated in a lynching. Honest doctors who prescribe medicines that…

Read More The Stench of Politics is Endangering Lives by Corroding the Practice of Medicine
Miscellaneous

FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP
October 26, 2006November 21, 2014

FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…

Read More FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP
Publication Integrity

Journal Publishers Hire PR “Pit Bull” to Attack Open Access_Nature
February 3, 2007November 21, 2014

The journal, Nature, reports that the American Association of Publishers (AAP) has hired Eric Dezenhall to fight against open access scientific articles.

Read More Journal Publishers Hire PR “Pit Bull” to Attack Open Access_Nature
Miscellaneous

VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10
October 26, 2006November 21, 2014

VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10 Mon, 8 Nov 2004 To hear from FDA Office of New Drugs Acting Director Sandra Kweder, MD, in an interactive discussion of what the withdrawal of the blockbuster drug means for the agencys drug safety programs, the COX-2 inhibitor class…

Read More VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10

Similar Posts